Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


International Tender Of Medical Devices Starts Year On High Note

This article was originally published in PharmAsia News

Executive Summary

China Tendering and Procurement Index for medical devices designed by monitors the public bidding of medical devices to capture the scale and trend of such activities locally. According to statistics compiled, the number of tenders announced in Q1 2008 was 339, up 27.44 percent over the same period last year; tenders approved hit 517 in the quarter, an increase of 21.08 percent over the same period in 2007. Philips leads in color ultrasound equipment for winning almost 30 percent of the total tenders put out. Siemens, Philips, GE and Toshiba together corner 97 percent of CT bids, while GE dominates half of MR projects. (Click here for more - Chinese language)

You may also be interested in...

Siemens Healthineers Gets Varian In 16.4Bn Deal To Enter Cancer Treatment Market

In a bold move to expand into cancer treatment markets, Siemens Healthineers has agreed to a $16.4bn all-cash deal to acquire radiation therapy leader Varian.

Coronavirus Update: Russia Plans First Vaccinations In October

Concern and skepticism about Russia's rapid vaccine roll-out. Meanwhile Japan is latest to reach reaches deal with Pfizer/BioNTech.

Sun Loses Shine In Q1, Testing Times In US

Sun’s Q1 earnings were dented by provisions related to the generic pricing investigation settlement with the US Department of Justice of arm Taro, and the impact of pandemic-related lockdowns. Some clinic-administered products bore the brunt of lock-downs in parts of the US, though market share was unaffected.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts